Navigation Links
Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
Date:8/5/2008

SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, will announce financial results for its second quarter ended June 30, 2008, on Thursday, August 7, 2008, after the markets close. The announcement will be followed by a live webcast and conference call at 2:00 p.m. Pacific Time.

Orexigen management will host the call and webcast to discuss results for the second quarter ended June 30, 2008, and recent business highlights. The live call may be accessed by phone by calling (800) 860-2442 (domestic) or (412) 858-4600 (international). The webcast can be accessed live on the investor relations section of the Company's Web site at http://www.orexigen.com and will be archived for 14 days following the call.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. The Company's lead combination product candidates targeted for obesity are Contrave(R), which is in Phase III clinical trials, and Empatic(TM), which is in the later stages of Phase II clinical development. Both product candidates take advantage of the Company's understanding of how the brain appears to regulate appetite and energy expenditure, as well as the mechanisms that come into play to limit weight loss over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
2. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
3. VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
4. CV Therapeutics Reports 2008 Second Quarter Financial Results
5. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
6. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
7. Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement
8. United Therapeutics Reports Second Quarter 2008 Financial Results
9. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent
10. Silence Therapeutics Patent Update
11. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... A new clinical study presented... shows that three-dimensional (3-D) automated ultr...tware during an in vitro fertilization (IVF) cycle...manual measurement of the follicles. , ...-- The Advanced Fertility Center of Chicago has ju...
(Date:11/30/2009)... , COLUMBUS, Ohio, Nov. 30 The...or one of the nation,s first minority business ear...n Cleveland December 3, is called "Transforming th...iness Early-Stage Capital Summit." It will feature...nority business leaders and local minority entrepr...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCa...tage vaccine company, announced today that the com...Care Conference 2009 on December 2, 2009 at 12:30 ...ovavax will provide an overview of the company,s b...s and upcoming milestones. A link to the live aud...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCa...day it has completed enrollment in the Phase II cl...2008/2009 recommended strains) VLP vaccine candida...er adults). This randomized, double-blind, active...ility and immunogenicity of two different doses (1...
Breaking Biology Technology:Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4
... vectors for studying signal transduction pathways...ratagene Cloning Systems, Inc. , Enhancer elemen...r signal,transduction pathways. For simple, rapi...ation of these pathways, Stratagene has designed t...way cis-reporting systems. Each of the cis-reporte...
...cilitate study of DNA mismatch repair , , ... Stratagene has designed RT-PCR primer sets fro...hese genes code for specialized proteins,that pa...n DNA. We have,assembled primer pairs specific f...and mouse (mMSH2, mGTBP, mPMS2 and Rep-3) mismatch...
...,, Reliable restriction enzymes satisfy al...uplent ,Stratagene , Restriction endonucleases...aking the functional purity of critical importance...ee of contaminants that can potentially interfere ... that use digested DNA (i.e.,ligation or sequen...
Other Biology Technology:Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 2Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 3Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 4RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 2RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 3RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 4RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 5Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal,Performance 2Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal,Performance 3Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal,Performance 4
(Date:12/1/2009)...n July the scientists, one from the United States,...n Brutus, the leader of his wolf pack, on remote E...e. Their goal to finally find out what these "Nor...r in one of the harshest areas of the world., "W...," said David Mech, a renowned U.S. Geological Sur...
(Date:12/1/2009)...n a world first, a Monash University-led internati... to boost the output of the next generation of sol...collaboration with colleagues from the universitie...tandem dye-sensitised solar cells with a three-fol...d with previously reported tandem dye-sensitised s...
(Date:12/1/2009)... Antennas aren,t just for listening to the radio a...s to GPS devices. Research from North Carolina Sta...nna design creating shape-shifting antennas that ...ing from public safety to military deployment. , ...als, but there are limitations to how far they can...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Innovation puts next-generation solar cells on the horizon 2Shape shifters: Researchers create new breed of antennas 2NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 1NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 2NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 3NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 4China Nepstar Chain Drugstore to Announce Second Quarter 2009 Financial Results on August 24 53698 1China Nepstar Chain Drugstore to Announce Second Quarter 2009 Financial Results on August 24 53698 2Brain Fitness Reduces Risk of Onset of Depressive Symptoms 53695 1Brain Fitness Reduces Risk of Onset of Depressive Symptoms 53695 2
...ere are only four specimens of the Yangtze giant s...hree in captivity. In order to save this species f...dlife Conservation Society (WCS) and the Turtle Su... partners from two Chinese zoos and the China Zoo ...roductive, more than 80-year-old, female, living i...
...earchers will present findings on a variety of NAS...8 Joint Assembly of the American Geophysical Union... 30 at the Greater Fort Lauderdale-Broward County ...derdale, Fla. Sessions are open to registered news...ions, in chronological order: , Evaluation of Low...
...HLAND, Wash. -- The pipes that rise from oil field...e fossil fuels and dump carbon dioxide into the ai...ructure of a catalytic material that can turn meth...insight lays the foundation for converting excess ...ls. , "There,s a big interest in doing something ...
Other Biology News:Relocation of endangered Chinese turtle may save species 2NASA presentations at American Geophysical Union Joint Assembly 2NASA presentations at American Geophysical Union Joint Assembly 3NASA presentations at American Geophysical Union Joint Assembly 4NASA presentations at American Geophysical Union Joint Assembly 5Halting methane squanderlust 2Halting methane squanderlust 3
Goat Anti-Human / Mouse / Rat AMPK beta 1 Polyclonal Antibody, Unconjugated from R&D Systems
...c peptide derived from the N-terminal region of hu... for the N-terminus of the ~225 kDa ZO-1 protein. ...s: MDCK-II A431 Caco-2 Rat-1 NRK-52E cells frozen ...er terminal tissues Human pancreas prostate and sm...
Rabbit Anti-Syntrophin alpha 1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Mitotic Kinesin-Like Protein-1 (MKLP-1, KNSL5) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: